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Introduction
Rapamycin, an antifungal, anticancer, and immunosuppressive 
compound produced by a soil bacterium from Rapa Nui (better 
known as Easter Island), was discovered in 1975 (Vézina et al., 
1975; Benjamin et al., 2011). The isolation of yeast mutants re-
sistant to the growth-inhibitory properties of rapamycin led to the 
discovery of TOR (target of rapamycin; Heitman et al., 1991; 
Kunz et al., 1993). It was subsequently found that TOR is a highly 
conserved controller of cell growth and that mammalian TOR 
(mTOR) is implicated in human disease (Menon and Manning, 
2008; Dazert and Hall, 2011; Laplante and Sabatini, 2012).
The protein kinase TOR functions in two structurally and 
functionally distinct multiprotein complexes termed TOR com-
plex 1 (TORC1 in yeast, mTORC1 in mammals) and TOR com-
plex 2 (TORC2 in yeast, mTORC2 in mammals; Wullschleger 
et al., 2006; Loewith and Hall, 2011; Laplante and Sabatini, 
2012). mTORC1 is composed of mTOR, raptor, and mLST8 
(Saccharomyces cerevisiae orthologues are TOR1, Kog1, and 
LST8, respectively). mTORC1 regulates cell growth (accumula-
tion of cell mass) through coordination of protein anabolism 
(Averous and Proud, 2006; Ma and Blenis, 2009), nucleotide bio-
synthesis (Ben-Sahra et al., 2013; Robitaille et al., 2013), lipo-
genesis, glycolysis (Laplante and Sabatini, 2009; Peterson et al., 
2011), and autophagy (Ganley et al., 2009; Hosokawa et al., 
2009). mTORC2 is composed of mTOR, rictor, SIN1, and mLST8 
(S. cerevisiae orthologues are TOR2, Avo3, Avo1, and LST8, 
respectively). mTORC2 controls growth by regulating lipogen-
esis, glucose metabolism (García-Martínez and Alessi, 2008; 
Hagiwara et al., 2012; Yuan et al., 2012), the actin cytoskeleton 
(Cybulski and Hall, 2009; Oh and Jacinto, 2011), and apoptosis 
(Datta et al., 1997).
TOR has been found at several cellular locations (Tables 1 
and 2; Malik et al., 2013), which has brought cell biology to the 
forefront of the TOR signaling field. In this review, we discuss 
the subcellular localization of the TOR complexes vis-à-vis their 
function and regulation. However, before starting our discussion, 
it is important to note several caveats in determining the subcel-
lular location of a protein or complex. Antibodies can be nonspe-
cific, overexpressed or tagged proteins can exhibit aberrant 
localization, different fixation or lysis methods can influence lo-
calization, and isolated organelles can be contaminated with other 
organelles. Additionally, detection of one component of a TOR 
complex does not necessarily reflect localization of an entire 
complex. Furthermore, especially when dealing with highly reg-
ulated pathways, it is essential to take nutrient, stress, and cell 
cycle status into account and to consider that commonly used cell 
lines present mutations that might affect subcellular localization. 
Thus, when evaluating localization of TOR, or any other protein, 
it is advisable to consider several complementary approaches be-
cause no single technique is without weakness.
Localization of mTORC1
mTORC1 at the lysosome.  mTORC1 is activated directly 
by GTP-bound Rheb on the surface of the lysosome (Fig. 1, 
Table 1). Two conditions need to be fulfilled for mTORC1 to be 
activated. One is that mTORC1 needs to translocate to the lyso-
some, a process stimulated by nutrients and the Rags (see next 
paragraph), where it encounters Rheb. The other is that Rheb 
needs to be activated, i.e., converted from a GDP- to a GTP-bound 
form, in response to growth factors. Rheb is a farnesylated GTPase 
that is anchored to the surface of the lysosome (Saito et al., 2005; 
Sancak et al., 2008). Rheb is inhibited by its GAP, a heterotrimer of 
TSC1 (tuberous sclerosis complex 1), TSC2, and TBC1D7 that is 
also on the lysosome. Growth factor–stimulated Akt phosphory-
lates and inhibits the TSC complex to activate Rheb, but it is not 
Target of rapamycin (TOR) forms two conserved, structur-
ally distinct kinase complexes termed TOR complex 1 
(TORC1) and TORC2. Each complex phosphorylates a 
different set of substrates to regulate cell growth. In mam-
mals, mTOR is stimulated by nutrients and growth factors 
and inhibited by stress to ensure that cells grow only dur-
ing favorable conditions. Studies in different organisms 
have reported localization of TOR to several distinct sub-
cellular compartments. Notably, the finding that mTORC1 
is localized to the lysosome has significantly enhanced 
our understanding of mTORC1 regulation. Subcellular 
localization may be a general principle used by TOR to 
enact precise spatial and temporal control of cell growth.
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particularly effective activator of Rag. Leucine is also an allo-
steric activator of glutamate dehydrogenase (GDH) that deami-
nates glutamate to produce -ketoglutarate. -Ketoglutarate is 
a cofactor for prolyl hydroxylases which may in turn, by an un-
known mechanism, activate Rag (Durán et al., 2012a). Interestingly, 
under prolonged amino acid starvation, mTORC1 is reactivated 
by amino acids derived from autophagosomal lysis, thus pre-
venting further autophagy (Yu et al., 2010).
Active Rag recruits mTORC1 to Rheb on the surface of the 
lysosome. Rag was originally suggested to deliver mTORC1 
from the cytoplasm to the lysosome, with the implication that Rag 
itself shuttles on and off the lysosome (Sancak et al., 2008; 
Zinzalla and Hall, 2008). However, a more recent study that 
directly examined the cellular location of Rag showed that it ap-
pears to be fixed to the lysosome, from where it recruits mTORC1 
to the lysosomal surface (Sancak et al., 2010). Most recently, it 
has again been suggested that Rag captures mTORC1 in the 
cytoplasm and then shuttles it back to the lysosomal surface 
(Bar-Peled et al., 2012). Furthermore, the E3 ubiquitin ligase 
TRAF6 and the signaling adaptor p62 appear to be involved in 
the recruitment of mTORC1 to the lysosome in response to amino 
acids (Linares et al., 2013). Thus, the mechanism by which Rag 
mediates lysosomal localization of mTORC1 remains to be deter-
mined. Once on the lysosome, mTORC1 forms a four-component 
super complex with v-ATPase, Ragulator, and Rag, as suggested 
by coimmunoprecipitation of mTORC1 with at least Ragulator 
and Rag (Sancak et al., 2010).
mTORC1 signaling in cells lacking TSC is resistant to 
growth factor withdrawal but still responsive to amino acids 
(Smith et al., 2005; Roccio et al., 2006). This indicates that to 
known where Akt meets the TSC complex. Akt is generally as-
sumed to be activated at the plasma membrane by PDK1 after 
growth factor stimulation (Hemmings and Restuccia, 2012).
mTORC1 translocation to the lysosome is controlled by 
the Rag GTPase and the so-called Ragulator, in response to 
amino acids (Kim et al., 2008; Sancak et al., 2008, 2010; Jewell 
et al., 2013). Rag is a heterodimeric GTPase consisting of 
RagA or B in complex with RagC or D. Ragulator, the GEF and 
lysosomal anchor for Rag, is a pentameric complex consisting 
of p14, p18, MP1, HBXIP, and C7orf59 (also known as LAM-
TOR1–5; Bar-Peled et al., 2012). Amino acids stimulate gua-
nine nucleotide exchange in Rag. How does Rag sense amino 
acids to activate mTORC1? There may be more than one mech-
anism. Zoncu et al. (2011) have proposed that amino acids are 
sensed in the lumen of the lysosome via the v-ATPase, which 
then activates Rag via Ragulator and possibly the recently de-
scribed Rag GAPs (Bar-Peled et al., 2013; Panchaud et al., 
2013; Petit et al., 2013; Tsun et al., 2013). Activation of Rag re-
quires ATP hydrolysis by the v-ATPase, but the function of the 
v-ATPase in establishing a lysosomal proton gradient appears 
to be dispensable. Ögmundsdóttir et al. (2012) have reported 
that the lysosomal proton-assisted amino acid transporter PAT1, 
which pumps amino acids out of the lysosomal lumen, interacts 
directly with Rag to activate mTORC1. However, as part of 
their argument that amino acids are sensed in the lysosomal 
lumen, Zoncu et al. (2011) reported that PAT1 overexpression 
inactivates mTORC1. The mechanism by which the v-ATPase 
actually senses amino acids to activate Ragulator–Rag remains 
to be determined. Durán et al. (2012b) have proposed that leu-
cine (and glutamine) is sensed via glutaminolysis. Leucine is a 
Table 1. Lysosome localization of TORC1
Pathway Mechanism of localization Cell type Technique Reference
mTORC1 Rheb localizes to the late  
endosome/lysosome
MDCK; HeLa;  
1321N1
Confocal live-cell imaging;  
expression of GFP-Rheb
Saito et al., 2005
mTORC1 The TSC complex is at the lysosome HeLa Wide-field imaging; PFA fixation;  
endogenous TSC2
Dibble et al., 2012
mTORC1 Amino acids stimulate mTOR  
translocation from the cytoplasm  
to the lysosome in a Rag- and Ragulator- 
dependent manner; Rheb, Ragulator,  
and Rags are at the lysosome  
independently of amino acids
HEK293T Confocal imaging; PFA fixation;  
endogenous mTOR, raptor,  
RagA/B, RagC; validation of  
antibody expression of GFP-Rheb,  
GFP-RagB/C/D, GFP-LAMTOR1,  
HA-raptor, myc-mTOR, FLAG-raptor,  
FLAG-LAMTOR4, FLAG-LAMTOR5
Sancak et al., 2008, 2010; 
Bar-Peled et al., 2012
mTORC1 Glutaminolysis stimulates mTOR  
translocation from the cytoplasm  
to the lysosome
U2OS Wide-field imaging; PFA fixation;  
endogenous mTOR
Durán et al., 2012b
Yeast TORC1 Tco89 (component of TORC1)  
is at the plasma membrane and  
the vacuole/lysosome
S. cerevisiae Immuno-EM; PFA fixation;  
genomically tagged Tco89-Myc
Reinke et al., 2004
Yeast TORC1 TORC1 (Tco89; Kog1; Sch9; TOR1)  
is mainly at the vacuole/lysosome
S. cerevisiae Live-cell, wide-field, and confocal  
imaging; genomically tagged  
Tco89-GFP, Kog1-GFP,  
Sch9-GFP, TOR1-GFP
Huh et al., 2003;  
Urban et al., 2007;  
Sturgill et al., 2008
Yeast TORC1 TORC1 (Tco89; Ego1; Sch9; TOR1)  
is mainly at the vacuole/lysosome,  
and this localization is independent  
of amino acid (Leu) availability
S. cerevisiae Live-cell imaging; genomically  
tagged Tco89-GFP, Ego1-GFP,  
Sch9-GFP, TOR1-GFP
Binda et al., 2009
This table groups the most important reports that link TORC1 and mTORC1 to the lysosome. By using a range of different techniques, distinct components of TORC1 
have consistently been identified at the lysosome in different cell types. PFA, paraformaldehyde; TSC, tuberous sclerosis complex.
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activity is unknown. Inhibition of mTORC1 activity with rapa-
mycin does not affect mTORC1 localization to the lysosome 
(Sancak et al., 2008), and kinase-dead mTORC1 still localizes to 
lysosomes (Tabatabaian et al., 2010). Finally, energy stress pre-
vents assembly and lysosomal localization of mTORC1, through 
the Tel2-Tti1-Tti2 (TTT)–RUVBL1/2 complex (Kim et al., 
2013). Tel2 and Tti1 are critical factors for the assembly and sta-
bility of mTORC1/2 and other PIKK family members (Takai 
et al., 2007; Kaizuka et al., 2010).
What does mTORC1 do once it is activated on the surface 
of the lysosome? Does it remain on the lysosome to phosphorylate 
activate mTORC1, Rheb needs amino acid–induced targeting of 
mTORC1 to the lysosome. On the other hand, forced localization 
of mTORC1 to the lysosome renders cells insensitive to amino 
acids and independent of Rag, but still dependent on Rheb and 
growth factors (Sancak et al., 2010). Overexpression of Rheb can 
activate mTORC1 even under amino acid starvation, possibly by 
enabling interaction between mislocalized Rheb and mTORC1 
at a site(s) away from the lysosome (Inoki et al., 2003; Smith et al., 
2005). Interestingly, amino acid starvation changes the location 
of the entire lysosome within the cell (Korolchuk et al., 2011), 
but the effect of this altered lysosomal localization on mTORC1 
Table 2. Localization of TORC1 to other organelles
Pathway Mechanism of localization Cell type Technique Reference
mTORC1 Rheb is at the ER and the Golgi HEK293 Confocal imaging; expression  
of EGFP-Rheb
Buerger et al., 2006
mTORC1 Rheb and the TSC complex are  
at the peroxisome
FAO; HepG2;  
MEF; HeLa
Confocal imaging and subcellular frac-
tionation; quantification of  
colocalization; endogenous TSC1, 
TSC2, and Rheb
Zhang et al., 2013
mTORC1 The TSC complex is mainly  
cytoplasmic
COS; HeLa Wide-field imaging and subcellular  
fractionation; PFA fixation;  
expression of TSC1 and TSC2
van Slegtenhorst et al., 1998; 
Nellist et al., 1999
mTORC1 The TSC complex is cytoplasmic  
and nuclear; Akt stimulates TSC  
translocation from the cytoplasm  
to the nucleus
NIH3T3; HeLa; 
HEK293; Rat-1
Subcellular fractionation Rosner and Hengstschläger, 
2007; Rosner et al., 2007, 
mTORC1 mTOR is at ER, Golgi, and in the 
nucleus; Rheb is cytoplasmic and 
nuclear; mTORC1 (mTOR, raptor)  
is in punctate structures upon  
amino acid starvation
HEK293; CHO;  
HeLa
Single photon FRET-FLIM on live cells; 
expression of mTOR-EGFP,  
Ds-Red-raptor, and Rheb-EGFP
Yadav et al., 2013
mTORC1 mTOR and raptor are highly  
abundant in the nucleus but  
mTORC1 integrity is higher in  
the cytoplasm
HEK293; NIH3T3;  
IMR-90; MRC-5; WI-38
Subcellular fractionation Rosner and Hengstschläger, 
2008
mTORC1 mTORC1 (mTOR, raptor) is in  
the nucleus and the cytoplasm; 
mTORC1 phosphorylates  
NFACTc4 in the nucleus; mTOR  
binds to rDNA, rDNA, and tRNA 
genes in a rapamycin-sensitive  
manner; serum stimulates mTOR  
binding to hnRNPs
COS; HEK293; HeLa Subcellular fractionation; ChIP Yang et al., 2008;  
Goh et al., 2010;  
Kantidakis et al., 2010;  
Shor et al., 2010;  
Tsang et al., 2010
mTORC1 During hypoxia, PML inhibits  
mTORC1 (mTOR) by sequestering  
it in the nucleus away from  
cytoplasmic Rheb
MEF; HEK293 Subcellular fractionation;  
confocal imaging; PFA fixation
Bernardi et al., 2006
mTORC1/2 mTOR shuttles from the cytoplasm  
to the nucleus
HEK293; CV-1 Wide-field imaging and subcellular  
fractionation; PFA fixation;  
expression of mTOR-FLAG
Kim and Chen, 2000
mTORC1/2 mTOR is predominantly nuclear  
except in HEK293, where it is  
excluded from the nucleus
HEK293; Rh30;  
Rh41; IMR90; HCT8; 
HCT29; HCT116
Confocal imaging and subcellular  
fractionation; PFA fixation;  
endogenous mTOR
Zhang et al., 2002
mTORC1 mTOR and raptor are associated  
with mitochondria; mTOR is  
associated with the mitochondrial 
channel VDAC
Jurkat; HEK293 Subcellular fractionation Schieke et al., 2006; 
Ramanathan and Schreiber, 
2009
Yeast TORC1 TOR1 is mainly nuclear, and  
nutrient starvation or rapamycin treat-
ment induce translocation  
to the cytoplasm
S. cerevisiae Wide-field imaging and subcellular  
fractionation; endogenous TOR1
Li et al., 2006
This table groups the most important reports that link TORC1 and mTORC1 to sites apart from the lysosome. By using comparable techniques to those that revealed 
lysosomal localization of mTORC1 (Table 1), distinct components of TORC1 have also been identified at other sites including the nucleus and mitochondria. ChIP, 
chromatin immunoprecipitation; PFA, paraformaldehyde.
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recruitment factor) is also on the peroxisome should be investi-
gated further. Future studies may reveal that mTORC1 is 
independently activated at different locations, possibly in re-
sponse to different cues, to phosphorylate physically separate 
substrates. To determine what mTORC1 is doing where will re-
quire defining where it phosphorylates particular substrates.
mTORC1 localization to lysosomes is usually monitored 
by immunofluorescence (IF) using an antibody against mTOR 
(Table 1). In these experiments, mTOR is dispersed (cytoplas-
mic) under amino acid–starved conditions, and punctate/ 
lysosomal upon re-addition of amino acids. An mTOR antibody 
should theoretically detect both mTORC1 and mTORC2, but 
mTORC2 does not localize to the lysosome and is unresponsive 
to amino acids. Thus, the mTOR antibody that is commonly 
used in these studies recognizes mTOR only in mTORC1, pos-
sibly because the epitope is masked in mTORC2. Another pos-
sibility would be that mTORC1 is much more abundant than 
mTORC2; however, immunoprecipitation experiments suggest 
this is not the case (Rosner and Hengstschläger, 2008). Other 
substrates locally? mTORC1 phosphorylates TFEB, a transcrip-
tion factor involved in autophagy, at the lysosome (Martina 
et al., 2012; Martina and Puertollano, 2013). However, presum-
ably active mTORC1 is also found at other cellular locations (see 
next subheadings), yet Rheb and Rag are required for activation of 
mTORC1 toward all examined substrates. It is unclear whether 
mTORC1 active in the cytoplasm (or in any other nonlysosomal 
location) remains bound to Rheb or, alternatively, it retains a 
“memory” of Rheb. We note that Rheb or TSC have also been 
identified on endomembranes other than the lysosome (Table 2; 
Henry et al., 1998; Plank et al., 1998; van Slegtenhorst et al., 1998; 
Nellist et al., 1999; Noonan et al., 2002; Murthy et al., 2004; 
Teleman et al., 2005; Buerger et al., 2006; Dibble et al., 2012; 
Yadav et al., 2013; Zhang et al., 2013). Of particular interest is 
the recent finding that both Rheb and TSC are on the peroxi-
some (Zhang et al., 2013). mTORC1 itself has so far not been 
found on the peroxisome but is inhibited by radical oxygen 
species generated in the peroxisome. The significance of TSC 
and Rheb on the peroxisome and whether Rag (or another 
Figure 1. Localization of mTORC1 signaling. mTORC1 is in the cytoplasm when amino acids levels are low. Addition of amino acids stimulates the re-
cruitment of mTORC1 in a Rag-dependent manner to the lysosomal surface. Upon growth factor stimulation, PI3K produces PIP3 in the plasma membrane, 
which in turn activates PDK1 and Akt. After phosphorylation by PDK1, Akt phosphorylates and thereby inhibits the TSC complex, possibly at the lysosome 
and the peroxisome. Reduced TSC complex GAP activity leads to an increase in GTP-bound Rheb. Rheb-GTP at the lysosomal surface directly binds to and 
activates mTORC1. Osmotic stress induces sequestration of mTORC1 in stress granules. Pools of mTORC1 have also been reported at other sites, including 
mitochondria and the nucleus.
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and nutrients to promote translation initiation (Holz et al., 2005; 
Harris et al., 2006; Proud, 2009; Sonenberg and Hinnebusch, 
2009). These events presumably take place in the cytoplasm.
Yeast TORC1. TORC1 in S. cerevisiae is on the limit-
ing membrane of the vacuole, the major nutrient reservoir in yeast 
cells (Reinke et al., 2004; Urban et al., 2007; Berchtold and 
Walther, 2009; Binda et al., 2009). The yeast vacuole is equiva-
lent to the lysosome in higher organisms. At the vacuole, TORC1 
localizes to discrete, PI3P-enriched subdomains (Sturgill et al., 
2008). Interestingly, in sharp contrast to mTORC1 at lysosomes, 
yeast TORC1 localization to the vacuole is independent of nutri-
ent availability (Binda et al., 2009). TORC1 at the vacuole/lyso-
some in both yeast and higher eukaryotes is the best-characterized 
localization of TORC1. However, as in mammals, the precise 
function of TORC1 at the vacuole/lysosome is unknown. A 
small fraction of yeast TORC1 is near the plasma membrane 
(Wedaman et al., 2003; Reinke et al., 2004). Curiously, Li et al. 
(2006) have reported that TORC1 is mainly nuclear.
TORC1 in other organisms. TORC1 in the alga 
Chlamydomonas is localized to the ER and regulates Bip (Grp78) 
phosphorylation (Díaz-Troya et al., 2008, 2011). TORC1 in plants 
is cytoplasmic and nuclear and regulates development and growth 
(Ren et al., 2011). In Drosophila, TOR appears to localize to vesic-
ular structures, possibly the lysosome (Hennig et al., 2006), and to 
a perinuclear structure, possibly the ER (Chang and Neufeld, 
2009). Although TORC1 is highly conserved in eukaryotes, sub-
cellular localization in organisms such as worms or fish has to our 
knowledge not been reported.
Localization of mTORC2
mTORC2 at mitochondria-associated ER mem-
brane. mTORC2 interacts with the ER proteins Hsp70 and 
Grp58 (Martin et al., 2008; Ramírez-Rangel et al., 2011), is sen-
sitive to ER stress (Hosoi et al., 2007; Yung et al., 2011; Chen 
et al., 2011; Appenzeller-Herzog and Hall, 2012), and is local-
ized to the ER (Boulbés et al., 2011). It is not fully understood 
which steps in mTORC2 signaling occur at the ER and in what 
chronological order. Akt, a major, direct mTORC2 substrate, is 
also found at the ER (Hresko and Mueckler, 2005; Boulbés 
et al., 2011), although the first step in Akt activation—PDK1-
mediated phosphorylation of the activation loop in Akt—is gen-
erally thought to occur at the plasma membrane. However, 
PDK1, PTEN (the PIP3 phosphatase), and PI3K have been 
observed on other organelles, including the ER (Daniele et al., 
1999; Lim et al., 2003; Downes et al., 2004). It is thus possible 
that the first step in Akt activation might also occur at the ER. 
Alternatively, PDK1-phosphorylated Akt may translocate to the 
ER to be phosphorylated by mTORC2. It is unclear whether re-
ported cotranslational phosphorylation of Akt and IMP1 by 
mTORC2 (Oh et al., 2010; Dai et al., 2013) occurs at the ER.
There are longstanding indications that mTORC2 is also 
associated with mitochondria. Mitochondrial membrane poten-
tial, respiration, and the phosphorylation status of several mito-
chondrial proteins are changed upon rapamycin treatment or 
rictor knockdown in Jurkat cells (Desai et al., 2002; Schieke 
et al., 2006). As noted earlier, mTORC2 is highly sensitive to 
rapamycin in Jurkat cells (Sarbassov et al., 2006). Furthermore, 
antibodies that detect mTOR at mitochondria and the ER might 
detect an epitope exposed only in mTORC2. Finally, immuno-
fluorescence experiments with antibodies against mTOR or 
raptor have generally detected only cytoplasmic/lysosomal 
mTORC1, yet other approaches have revealed mTORC1 at other 
sites (discussed later). This may be due to mTORC1 being mainly 
cytoplasmic/lysosomal. Alternatively, localization to other sites 
may require specific conditions such as stress.
mTORC1 in the nucleus. Components of the mTORC1 
signaling pathway, including mTOR, raptor, and S6K, have been 
detected in the nucleoplasm (Table 2; Kim and Kahn, 1997; Kim 
and Chen, 2000; Zhang et al., 2002; Kikani et al., 2005; Lian and 
Di Cristofano, 2005; Rosner et al., 2007; Yadav et al., 2013). 
However, although mTOR and raptor are detectable inside the 
nucleus where they may have a role in transcription regulation 
(Bernardi et al., 2006; Cunningham et al., 2007; Yang et al., 2008; 
Goh et al., 2010; Kantidakis et al., 2010; Shor et al., 2010; Tsang 
et al., 2010), these nuclear versions appear not to form an intact 
mTORC1 (Fig. 1; Rosner and Hengstschläger, 2008).
mTORC1 in mitochondria. mTOR has been found 
at mitochondria (Fig. 1), and rapamycin treatment affects mito-
chondrial function in Jurkat cells (Paglin et al., 2005; Schieke 
et al., 2006; Ramanathan and Schreiber, 2009). However, it is 
unclear whether mTORC1 localizes to mitochondria because 
mTOR, instead of complex-specific rictor or raptor, was probed 
to investigate mTORC1 localization. Although rapamycin 
acutely inhibits only mTORC1, prolonged rapamycin treatment 
can also inhibit mTORC2 in certain cells (including Jurkat 
cells; Sarbassov et al., 2006). We speculate that at least some 
studies might have observed mTORC2 rather than mTORC1 at 
mitochondria (discussed later).
mTORC1 in stress granules. mTORC1 is seques-
tered in stress granules in response to stress in an astrin-dependent 
manner (Fig. 1; Thedieck et al., 2013). This localization is me-
diated by physical interaction with the kinase DYRK3 but is in-
dependent of DYRK3 kinase activity (Wippich et al., 2013). 
Yeast TORC1 is similarly targeted to stress granules in response 
to heat stress (Takahara and Maeda, 2012). Localization of 
mTORC1 to stress granules is a mechanism to sequester mTORC1 
and thus to arrest growth in unfavorable conditions.
mTORC1 at the plasma membrane. A recent re-
port suggests that the WD40 domain in raptor binds the lipid 
PI(3,5)P2, thereby targeting mTORC1 to the plasma membrane 
(Bridges et al., 2012). The authors observed that this lipid is 
generated at the plasma membrane and the lysosome, depend-
ing on the cell type, after insulin or amino acid stimulation, and 
speculate that PI(3,5)P2 binding could also contribute to lyso-
somal targeting. Interestingly, both PI(3,5)P2 and TORC1 are 
enriched at discrete sites on the yeast lysosome (known as the 
vacuole in yeast; Han and Emr, 2011), but it has yet to be deter-
mined whether TORC1 colocalizes with PI(3,5)P2.
mTORC1 in the cytoplasm. mTORC1, in particular 
under amino acid starvation conditions, exhibits a diffuse, cyto-
plasmic distribution. However, it may also have a function in 
the cytoplasm when active. mTORC1 associates with the gen-
eral translation initiation complex eIF3 and phosphorylates the 
translation inhibitor 4E-BP upon stimulation by growth factors 
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and calcium between the two organelles. MAM thereby controls 
mitochondrial metabolism and apoptosis (Rizzuto et al., 1998; 
Csordás et al., 1999). Several observations have linked mTORC2 
to MAM. First, mTOR and mLST8 interact with VDAC1 
(Ramanathan and Schreiber, 2009) and Grp75 (Behrends et al., 
2010), respectively. VDAC1 together with Grp75 and IP3R teth-
ers mitochondria to the ER to form MAM (Szabadkai et al., 
2006). Second, the MAM resident proteins IP3R, PACS2, and 
the VDAC-interacting protein hexokinase 2 (HK2) are Akt 
substrates (Simmen et al., 2005; Khan et al., 2006; Szado et al., 
2008; Aslan et al., 2009; Marchi et al., 2012), and Akt itself is 
associated with MAM (Giorgi et al., 2010). Third, MAM ap-
pears to have a role in modulating ER stress (Simmen et al., 
2010; Malhotra and Kaufman, 2011; Verfaillie et al., 2012), 
which in turn can inhibit mTORC2 (Appenzeller-Herzog and 
Hall, 2012). Fourth, liver-specific knockout of Mfn2 (Sebastián 
et al., 2012), a key MAM protein, confers a whole body pheno-
type strikingly similar to that of liver-specific rictor knockout 
(Hagiwara et al., 2012). Fifth, a recent proteomic study on MAM 
detected mTOR (Poston et al., 2013). These results suggest that 
the previously described mitochondrial and ER-associated 
mTORC2 might actually be at MAM.
mTOR localizes to structures in close proximity to the mitochon-
drial outer membrane (OMM; Desai et al., 2002) and interacts with 
VDAC, an OMM channel (Ramanathan and Schreiber, 2009), 
although these two studies did not address whether the observed 
mTOR localization was mTORC1 or mTORC2. We suggest that 
mitochondrial mTOR may correspond to mTORC2. This would be 
consistent with other studies linking mTORC2 to mitochondrial 
function (Wang et al., 2010; Colombi et al., 2011; Murata et al., 
2011; Hagiwara et al., 2012; Yuan et al., 2012; Wu et al., 2013). 
Furthermore, Akt has been detected at mitochondria (Bijur and 
Jope, 2003; Miyamoto et al., 2008; Antico Arciuch et al., 2009; 
Su et al., 2012), and another direct substrate of mTORC2, SGK1 
(serum- and glucocorticoid-inducible kinase 1), is primarily local-
ized to mitochondria (Engelsberg et al., 2006; Cordas et al., 2007). 
PTEN has been observed at mitochondria (Zhu et al., 2006; Zu 
et al., 2011) and mitochondria-associated ER membranes (MAMs; 
Bononi et al., 2013), although it is unclear whether mitochondrial 
PTEN functions as a PIP3 phosphatase.
Is there a link between mitochondrial mTORC2 and ER-
associated mTORC2? MAM is a subdomain of the ER that is 
physically tethered to mitochondria (Raturi and Simmen, 2012). 
The main function of MAM is to facilitate the transfer of lipids 
Figure 2. Localization of mTORC2 signaling. mTORC2 interacts with ribosomes in a PI3K-dependent manner. Upon growth factor stimulation, mTORC2 is 
recruited to MAMs, presumably from the cytoplasm. mTORC2 has also been observed in the nucleus and on lipid rafts at the plasma membrane.
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for mitochondrial ATP, thus providing more evidence that MAM 
localization is important for mTORC2 activity. Altogether, the 
above suggests that MAM is a signaling platform for mTORC2 
like the lysosome is for mTORC1 (Fig. 2).
mTORC2 at the plasma membrane. mTORC2 
and its substrate Akt have been isolated from lipid rafts tradi-
tionally associated with the plasma membrane (Fig. 2; Hill 
et al., 2002; Partovian et al., 2008; Gao et al., 2011), although 
lipid raft domains also exist in the ER, where they form MAM 
(Poston et al., 2011; see previous section). Evaluation of rictor 
localization by immunofluorescence (Zhang et al., 2010) and 
subcellular fractionation (Boulbés et al., 2011) suggests that 
only a minor fraction of mTORC2 is at the plasma membrane.
mTORC2 in the nucleus. mTORC2 has been reported 
to shuttle between the cytoplasm and the nucleoplasm (Table 3, 
Fig. 2; Rosner et al., 2007; Rosner and Hengstschläger, 2008, 
2011, 2012). A nuclear function for mTORC2 is so far unknown.
TORC2 in yeast. TORC2 in yeast is at or near the plasma 
membrane (Kunz et al., 2000; Wedaman et al., 2003; Aronova 
et al., 2007; Sturgill et al., 2008; Berchtold and Walther, 2009). 
TORC2 near the plasma membrane might actually be at cortical 
ER, as suggested by its association with distinct membranous 
tracks just under the plasma membrane (Wedaman et al., 2003). It 
is currently unknown whether TORC2 can also localize to MAM 
in yeast, as this structure is structurally and functionally differ-
ent from mammalian MAM (Kornmann et al., 2009; Michel and 
Kornmann, 2012).
TORC2 in other organisms. TORC2 in Trypano-
somes localizes to both the ER and mitochondria (Barquilla 
et al., 2008). Although present in Dictyostelium, Drosophila, 
Caenorhabditis, and zebrafish, TORC2 localization has not yet 
been investigated in these organisms.
Considerations and future directions
A major question is, why is mTOR at different cellular locations? 
The initial response to this question is that mTOR phosphorylates 
A recent study that directly investigated mTORC2 local-
ization confirmed that mTORC2 indeed localizes to MAM 
(Fig. 2, Table 3; Betz et al., 2013). mTORC2 localization to 
MAM is stimulated by growth factors, and mTORC2 at MAM 
controls Akt and the Akt targets PACS2, IP3R, and HK2 to ulti-
mately control MAM integrity, calcium release, and mitochon-
drial physiology (Betz et al., 2013). Thus, it appears that MAM is 
a hub for mTORC2-Akt signaling. MAM regulates many physi-
ological functions including mitochondrial metabolism, the syn-
thesis and maturation of cholesterol, phospho- and sphingolipids, 
autophagy, and ER stress (Fujimoto et al., 2012; Raturi and 
Simmen, 2012; Verfaillie et al., 2012; Hamasaki et al., 2013), and 
is implicated in a number of diseases including diabetes, neuro-
degeneration, and cancer (Bononi et al., 2012; Leem and Koh, 
2012). Interestingly, mTORC2 is also linked to many of these 
processes and diseases, suggesting that they may be due to 
mTORC2 function (or dysfunction) at the MAM signaling hub.
How does mTORC2 localization to MAM relate to activa-
tion of mTORC2 by ribosome association? Electron micros-
copy images (Ruby et al., 1969; Csordás et al., 2006; Lebiedzinska 
et al., 2009) and proteomic profiling (Poston et al., 2011, 2013; 
Zhang et al., 2011) of MAM suggest that ribosomes are present 
at this ER subdomain. Calnexin, a MAM-enriched chaperone 
(Lynes et al., 2012), interacts with the MAM protein PACS2 and 
anchors ribosomes at the ER and possibly MAM (Lakkaraju 
et al., 2012). The role of MAM ribosomes has yet to be defined. 
However, certain viruses that replicate at MAM, such as CMV, 
actively recruit the translation machinery to MAM (Zhang 
et al., 2011), suggesting that ribosomes at MAM are required 
for translation. Interestingly, CMV infection also increases 
mTORC2 activity (Clippinger et al., 2011), and a MAM defi-
ciency results in reduced mTORC2 activity (Sebastián 
et al., 2012). Thus, it appears that ribosomes at MAM and acti-
vation of mTORC2 are functionally linked. A recent report sug-
gests that ATP regulates mTORC2 integrity (Chen et al., 2013). 
At MAM, mTORC2 is in a complex with VDAC, the exit channel 
Table 3. Mitochondria, ER, MAM, and other localization of mTORC2
Pathway Mechanism of localization Cell type Technique Reference
mTORC2 mTORC2 (mTOR, rictor) is  
mainly at the ER
MDA-MB-435; A549 Confocal imaging and subcellular  
fractionation; PFA fixation;  
endogenous mTOR and rictor
Boulbés et al., 2011
mTORC1/2 mTOR is associated with  
mitochondria
NIH3T3 Confocal imaging, subcellular  
fractionation, and immuno-EM;  
PFA fixation; endogenous mTOR
Desai et al., 2002
mTORC2 mTORC2 (mTOR; Sin1; rictor)  
is at MAM
HeLa; MEF; mouse liver Confocal imaging, subcellular  
fractionation, and immuno-EM; PFA  
fixation; endogenous mTOR, Sin1,  
and rictor; validation of antibody
Betz et al., 2013; Poston et al., 
2013
mTORC2 A part of mTORC2 (mTOR;  
rictor; Sin1) is nuclear; rapamycin 
treatment induces translocation  
of mTORC2 to the cytoplasm
HEK293; IMR-90; 
NIH3T3
Subcellular fractionation Rosner et al., 2007; Rosner 
and Hengstschläger, 2008, 
2011, 2012
Yeast TORC2 TORC2 (TOR2; Bit61; Avo1-3)  
is at or near the plasma  
membrane, possibly cortical ER
S. cerevisiae Subcellular fractionation, immuno-EM,  
live-cell imaging, and wide-field and  
confocal imaging; PFA fixation;  
TOR2-GFP, Bit61-GFP, Avo1-3-GFP
Kunz et al., 2000; Wedaman 
et al., 2003; Aronova et al., 
2007; Sturgill et al., 2008; 
Berchtold and Walther, 2009
This table groups the most important reports that investigate TORC2 and mTORC2 localization. mTORC2 has consistently been identified in proximity to mitochondria, 
the ER, and MAM. Other studies suggest that mTORC2 is nuclear or at the plasma membrane. EM, electron microscopy; PFA, paraformaldehyde.
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functionally distinct substrates at different locations. Another 
possibility is that mTORC1 and mTORC2 sense different inputs 
at different locations. For example, mTORC1 at the lysosome 
senses amino acids, whereas mTORC1 at the peroxisome would 
sense peroxisome-generated hydrogen peroxide (Benjamin and 
Hall, 2013). The answer to the above question will be revealed as 
we learn more about the cellular biology of mTOR.
Several mTOR complex components, including mTOR, 
rictor, raptor, and Sin1 are phosphorylated in vivo. Although 
the functionality of most of these modifications is unclear, post-
translational modifications (PTMs), including phosphorylation, 
are prime suspects in regulating protein targeting. Farnesylation 
is a key determinant of Rheb subcellular localization to endo-
membranes (Buerger et al., 2006). Palmitoylation, a PTM that 
strongly affects protein localization, has not been reported for 
mTOR components; however, bioinformatic analysis (Ren 
et al., 2008) predicts at least one strong candidate palmitoylation 
site (C322) in the Sin1 isoform Sin1.5 (NP_001006619; unpub-
lished data). It is of interest to determine the potential role of 
PTMs in the localization of TOR pathway components.
TORC1 localization is well characterized and consistent in 
mammalian and yeast cells. It has been shown by many methods 
that both yeast TORC1 and mTORC1 are mainly at the vacuole/
lysosome. TORC2 localization is more ambiguous. mTORC2 is 
at MAM, and yeast TORC2 is at the plasma membrane. Although 
this diversity can be attributed to cell type specificity, there might 
also be multiple pools of TORC2 (or TORC1), each at a different 
subcellular location. Furthermore, there are at least three differ-
ent mTORC2 pools, defined by different Sin1 isoforms (Frias 
et al., 2006). These alternatively spliced Sin1 isoforms differ in 
containing PH and RBD (Ras binding) domains, and thus present 
an interesting mechanism for how different mTORC2 com-
plexes might localize to different compartments. Future studies 
may reveal the molecular basis of differently localized TORC1 or 
TORC2 subpopulations.
Another important unresolved issue is how the TORCs at 
different locations are regulated. For example, is all mTORC1 
activated by Rheb and Rag at the lysosome and then distributed 
to other sites, or are there so far undetected amounts of Rheb and 
Rag at other locations? The following questions have also not 
been addressed carefully and are interesting points for future in-
vestigation. Is there a specific site inside the cell where TOR 
complexes are assembled? What role do lipids play in TOR lo-
calization? What forces/factors mediate TOR translocation in the 
cell? How does disease influence mTOR localization and vice 
versa? Does TOR localization play a role in developmental pro-
cesses? To answer these questions, new technologies that allow 
sensitive detection of intact mTOR complexes in live cells, such 
as FRET-FLIM (Ishikawa-Ankerhold et al., 2012), may be nec-
essary. Other methodological or technological developments such 
as proximity ligation (Blazek et al., 2013) and super-resolution 
microscopy, respectively, will also enhance our understanding of 
TOR localization. The ultimate goal is to obtain a comprehen-
sive, dynamic, and spatial model of TOR signaling.
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